1. 1) Marks D, Thorogood M, Neil HA, et al: A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia. Atherosclerosis 2003; 168: 1–14
2. 2) Slack J: Risks of ischemic heart-disease in familial hyperlipoproteinaemic states. Lancet 1969; 2: 1380–1382
3. 3) Thompson GR, Maher VM, Matthews S, et al: Familial hypercholesterolemia regression study: a randomised trial of low-density-
lipoprotein apheresis. Lancet 1995; 345: 811–816
4. 4) Nordestgaard BG, Chapman MJ, Humphries SE, et al: Familial hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478–3490
5. 5) Sturm AC, Knowles JW, Gidding SS, et al; Convened by the Familial Hypercholesterolemia Foundation: Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol 2018; 72: 662–680